Navigation Links
CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion
Date:12/15/2008

A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

VOORHEES, N.J., Dec. 15 /PRNewswire/ -- Cytomegalovirus (CMV) infection is a serious condition and an important cause of morbidity and mortality in recipients of hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT). Controversy exists regarding the best method for CMV prevention. It is important for healthcare professionals working with transplant recipients to be aware of the advantages and limitations of the current strategies available for managing CMV infection and disease in this population.

To address the need for current education on CMV infection in transplant recipients, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture for physicians, pharmacists, nurses, and other infectious disease specialists. This activity is supported by an educational grant from ViroPharma Incorporated.

Faculty for this virtual lecture include Michael J. Boeckh, MD, Associate Member of the Program of Infectious Diseases at Fred Hutchinson Cancer Research Center and Associate Professor at the University of Washington School of Medicine in Seattle, Washington; John R. Wingard, MD, Professor and Price Chair of Medicine in the Department of Pediatrics and Director of the Blood and Bone Marrow Transplant Program at the University of Florida Shands Cancer Center in Gainesville, Florida; Raymund R. Razonable, MD, Assistant Professor of Medicine at the Mayo Clinic College of Medicine in Rochester, Minnesota; and Ajit P. Limaye, MD, Associate Professor of Laboratory Medicine and Co-Director of the Clinical Microbiology Laboratory and Director of the Organ Transplant Infectious Diseases Program at the University of Washington Medical Center in Seattle, Washington.

Healthcare professionals can access CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion virtual lecture atwww.RMEI.com/CMV053.

"Robert Michael Educational Institute LLC is committed to providing healthcare professionals with opportunities for quality, innovative, and convenient continuing medical education," says President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited, and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit http://www.rmei.com/currentprograms


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
3. Computers help chemists fight emerging infections
4. Infection contributes to the high rates of oropharyngeal cancers
5. Jefferson immunology researchers halt lethal rabies infection in brain
6. SIV infection of natural hosts provides new insights into HIV disease complexity
7. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
8. Natural aorta grafts have few side effects for infection-prone patients
9. Common misdiagnosis: most women believe they have a yeast infection when they dont
10. Patient Safety Authority Board of Directors Names Infection Advisory Panel
11. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... ORLANDO, Fla. , Oct. 2, 2017  AllianceRx ... services company formed by Walgreens and pharmacy benefit manager ... of its new brand, which included the unveiling of ... Fla. , as well as at a few ... introduces the new brand to patients, some of whom ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: